NCT06428084View on ClinicalTrials.gov

Comparative Efficacy of Dexamethasone - Ondansetron Versus Dexamethasone - Haloperidol in Reducing PONV

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2024

Conditions
Laparoscopic Cholecystectomy
Interventions
DRUG

Ondansetron

4 mg of ondansetron intravenously

DRUG

Haloperidol

1 mg of Haloperidol intravenously

Trial Locations (1)

40161

Hasan Sadikin General Hospital, Bandung

All Listed Sponsors
lead

Universitas Padjadjaran

OTHER